Search
Now showing items 1-1 of 1
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
(TÜBİTAK, 2020-02-13)
Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional ...